HK Stock Market Move | XPENG-W (09868) rose by nearly 5%. It is reported that Xiaopeng Motors has submitted a confidential application for a Hong Kong IPO.
Xiaopeng Motors (09868) rose nearly 5%, as of press time, rose 3.67%, reported at 83.3 Hong Kong dollars, with a turnover of 3.71 billion Hong Kong dollars.
XPENG-W(09868) rose nearly 5%, as of the time of publication, it rose 3.67%, to 83.3 Hong Kong dollars, with a turnover of 3.71 billion Hong Kong dollars.
On the news front, on January 12, according to market sources, Xiaopeng's flying car department - Xpeng Aeroht has appointed banks to prepare for its first public offering (IPO) in Hong Kong. It is reported that this Chinese electric vehicle manufacturer has chosen JPMorgan and Morgan Stanley as joint sponsors to promote the relevant listing work. Sources pointed out that Xpeng Aeroht has secretly submitted a share sale application, and the earliest possible listing time may be set for this year.
Public information shows that Xpeng Aeroht has recently rebranded its international brand as "Aridge". In terms of production capacity layout, the company's intelligent manufacturing base in Guangzhou covers an area of 120,000 square meters. According to the design plan, the factory is expected to achieve efficient production capacity of one flying car every 30 minutes in the future. It is reported that its first mass-produced flying car is scheduled to begin customer deliveries by the end of 2026.
Related Articles
.png)
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.

HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.
.png)
HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


